NCT04523701View on ClinicalTrials.gov

"Diagnostic Role of the White Test With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)"

PHASE3RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Bile Leakage
Interventions
DRUG

"white test (= the administration of SMOFlipid retrograde through the cystic duct)"

"white test (= the administration of SMOFlipid retrograde through the cystic duct)"

Trial Locations (5)

4031

RECRUITING

Clarunis Basel, Universitäres Bauchzentrum Basel, Basel

5001

RECRUITING

Department of Visceral Surgery, Cantonal Hospital of Aarau, Aarau

6004

RECRUITING

Kantonsspital Luzern, Lucerne

6900

RECRUITING

Ospedale Regionale di Lugano, Lugano

9001

RECRUITING

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Giulia Manzini

OTHER

NCT04523701 - "Diagnostic Role of the White Test With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)" | Biotech Hunter | Biotech Hunter